Literature DB >> 27312698

Diabetes remission off medications is not a suitable endpoint for comparing bariatric/metabolic surgery with pharmacotherapy.

Bruno Halpern1,2, Cintia Cercato3,4,5, Marcio C Mancini3,4,5.   

Abstract

Entities:  

Keywords:  Bariatric surgery; Diabetes pharmacotherapy; Diabetes relapse; Diabetes remission; Metabolic surgery; Obesity; Roux-en-Y gastric bypass; Sleeve gastrectomy; Type 2 diabetes; Weight loss

Mesh：

Year:  2016        PMID： 27312698     DOI： 10.1007/s00125-016-4007-3

Source DB:  PubMed          Journal:  Diabetologia        ISSN： 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  10 in total

1.  Treating diabetes with surgery.

Authors:  Bruce M Wolfe; Jonathan Q Purnell; Steven H Belle
Journal:  JAMA       Date:  2013-06-05       Impact factor: 56.272

2.  Incidence and remission of type 2 diabetes in relation to degree of obesity at baseline and 2 year weight change: the Swedish Obese Subjects (SOS) study.

Authors:  Kajsa Sjöholm; Pia Pajunen; Peter Jacobson; Kristjan Karason; C David Sjöström; Jarl Torgerson; Lena M S Carlsson; Lars Sjöström; Markku Peltonen
Journal:  Diabetologia       Date:  2015-04-30       Impact factor: 10.122

3.  Gastric bypass surgery vs intensive lifestyle and medical intervention for type 2 diabetes: the CROSSROADS randomised controlled trial.

Authors:  David E Cummings; David E Arterburn; Emily O Westbrook; Jessica N Kuzma; Skye D Stewart; Chun P Chan; Steven N Bock; Jeffrey T Landers; Mario Kratz; Karen E Foster-Schubert; David R Flum
Journal:  Diabetologia       Date:  2016-03-17       Impact factor: 10.122

4.  Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.

Authors:  Bernard Zinman; Christoph Wanner; John M Lachin; David Fitchett; Erich Bluhmki; Stefan Hantel; Michaela Mattheus; Theresa Devins; Odd Erik Johansen; Hans J Woerle; Uli C Broedl; Silvio E Inzucchi
Journal:  N Engl J Med       Date:  2015-09-17       Impact factor: 91.245

5.  Bariatric surgery versus intensive medical therapy for diabetes--3-year outcomes.

Authors:  Philip R Schauer; Deepak L Bhatt; John P Kirwan; Kathy Wolski; Stacy A Brethauer; Sankar D Navaneethan; Ali Aminian; Claire E Pothier; Esther S H Kim; Steven E Nissen; Sangeeta R Kashyap
Journal:  N Engl J Med       Date:  2014-03-31       Impact factor: 91.245

6.  Cardiovascular disease and mortality in patients with type 2 diabetes after bariatric surgery in Sweden: a nationwide, matched, observational cohort study.

Authors:  Björn Eliasson; Vasileios Liakopoulos; Stefan Franzén; Ingmar Näslund; Ann-Marie Svensson; Johan Ottosson; Soffia Gudbjörnsdottir
Journal:  Lancet Diabetes Endocrinol       Date:  2015-09-28       Impact factor: 32.069

7.  Three-Year Outcomes of Bariatric Surgery vs Lifestyle Intervention for Type 2 Diabetes Mellitus Treatment: A Randomized Clinical Trial.

Authors:  Anita P Courcoulas; Steven H Belle; Rebecca H Neiberg; Sheila K Pierson; Jessie K Eagleton; Melissa A Kalarchian; James P DeLany; Wei Lang; John M Jakicic
Journal:  JAMA Surg       Date:  2015-10       Impact factor: 14.766

8.  Weight Change-Adjusted Effects of Gastric Bypass Surgery on Glucose Metabolism: 2- and 10-Year Results From the Swedish Obese Subjects (SOS) Study.

Authors:  Kajsa Sjöholm; Elisabeth Sjöström; Lena M S Carlsson; Markku Peltonen
Journal:  Diabetes Care       Date:  2015-12-17       Impact factor: 19.112

9.  Roux-en-Y gastric bypass vs intensive medical management for the control of type 2 diabetes, hypertension, and hyperlipidemia: the Diabetes Surgery Study randomized clinical trial.

Authors:  Sayeed Ikramuddin; Judith Korner; Wei-Jei Lee; John E Connett; William B Inabnet; Charles J Billington; Avis J Thomas; Daniel B Leslie; Keong Chong; Robert W Jeffery; Leaque Ahmed; Adrian Vella; Lee-Ming Chuang; Marc Bessler; Michael G Sarr; James M Swain; Patricia Laqua; Michael D Jensen; John P Bantle
Journal:  JAMA       Date:  2013-06-05       Impact factor: 56.272

10.  Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.

Authors:  Steven P Marso; Gilbert H Daniels; Kirstine Brown-Frandsen; Peter Kristensen; Johannes F E Mann; Michael A Nauck; Steven E Nissen; Stuart Pocock; Neil R Poulter; Lasse S Ravn; William M Steinberg; Mette Stockner; Bernard Zinman; Richard M Bergenstal; John B Buse
Journal:  N Engl J Med       Date:  2016-06-13       Impact factor: 176.079
  10 in total
  1 in total

1.  Reconciliation of Type 2 Diabetes Remission Rates in Studies of Roux-en-Y Gastric Bypass.

Authors:  Deanna J M Isaman; Amy E Rothberg; William H Herman
Journal:  Diabetes Care       Date:  2016-10-13       Impact factor: 19.112
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.